Aldevron vs Wacker Biotech: CDMO Comparison
How does Aldevron compare to Wacker Biotech?
As of Mar 2026, Aldevron: 1 FDA inspection (including 1 NAI, 0 VAI and 0 OAI). Signal Score 80.3. Wacker Biotech: 1 FDA inspection (including 0 NAI, 1 VAI and 0 OAI), 13 EMA/MHRA GMP certificates. Signal Score 82.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of Aldevron and Wacker Biotech on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Wacker Biotech holds 13 active EMA GMP certificates; Aldevron does not appear in EudraGMDP.
Across the cross-modality scorecard, Wacker Biotech carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: Aldevron vs Wacker Biotech
How does Aldevron compare to Wacker Biotech?
On CDMO Signal's composite Signal Score, Aldevron is 80/100 and Wacker Biotech is 83/100; Aldevron has 1 FDA inspection on record vs 1 for Wacker Biotech; European coverage is 0 active EMA+MHRA certificates for Aldevron vs 13 for Wacker Biotech. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Aldevron or Wacker Biotech?
Both Aldevron and Wacker Biotech maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Aldevron has 1 FDA inspection on record; Wacker Biotech has 1.
How do Aldevron and Wacker Biotech compare on European GMP coverage?
Aldevron holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Wacker Biotech holds 13 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
What does the Signal Score gap mean in practice?
Aldevron carries a Signal Score of 80/100 and Wacker Biotech carries 83/100 — essentially tied for Wacker Biotech. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →